{"transactions":[{"id":707935,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2026-07-16T20:03:02.000Z","date":"2026-07-14","kind":"purchase","planned":false,"acquired":true,"shares":687285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable beginning on the later of (i) six months after issuance or (ii) the Authorized Share Increase Date (the \"Initial Exercise Date\").  \"Authorized Share Increase Date\" means the date on which an amendment to the Issuer's certificate of incorporation increasing the number of authorized shares of its common stock to an amount sufficient for the exercise in full of the Common Warrants is filed with and accepted by the State of Delaware, subject to approval of such amendment by its stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The term of exercise is equal to five and one-half years after the Initial Exercise Date."}],"balance_after":687285,"derivative":{"exercise_price":1.33,"underlying":"Common Stock","underlying_shares":687285},"source":{"system":"sec-edgar","filing":"0001193125-26-306083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000119312526306083/ownership.xml","form_type":"4"}},{"id":707934,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-16T20:03:02.000Z","date":"2026-07-14","kind":"purchase","planned":false,"acquired":true,"shares":687285,"price":1.455,"value":999999.675,"ownership":{"direct":true},"balance_after":2043661,"source":{"system":"sec-edgar","filing":"0001193125-26-306083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000119312526306083/ownership.xml","form_type":"4"}},{"id":707925,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2026-07-16T20:01:04.000Z","date":"2026-07-14","kind":"purchase","planned":false,"acquired":true,"shares":34364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable beginning on the later of (i) six months after issuance or (ii) the Authorized Share Increase Date (the \"Initial Exercise Date\").  \"Authorized Share Increase Date\" means the date on which an amendment to the Issuer's certificate of incorporation increasing the number of authorized shares of its common stock to an amount sufficient for the exercise in full of the Common Warrants is filed with and accepted by the State of Delaware, subject to approval of such amendment by its stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The term of exercise is equal to five and one-half years after the Initial Exercise Date."}],"balance_after":34364,"derivative":{"exercise_price":1.33,"underlying":"Common Stock","underlying_shares":34364},"source":{"system":"sec-edgar","filing":"0001193125-26-306072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526306072/ownership.xml","form_type":"4"}},{"id":707924,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-16T20:01:04.000Z","date":"2026-07-14","kind":"purchase","planned":false,"acquired":true,"shares":34364,"price":1.455,"value":49999.62,"ownership":{"direct":true},"balance_after":59067,"source":{"system":"sec-edgar","filing":"0001193125-26-306072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526306072/ownership.xml","form_type":"4"}},{"id":730230,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-22T13:00:05.000Z","date":"2026-06-18","kind":"purchase","planned":false,"acquired":true,"shares":24703,"price":1.21,"value":29890.63,"ownership":{"direct":true},"balance_after":24703,"source":{"system":"sec-edgar","filing":"0001664708-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000166470826000002/ownership.xml","form_type":"4"}},{"id":730249,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T13:00:04.000Z","date":"2026-06-18","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.22,"value":36600.0,"ownership":{"direct":true},"balance_after":1356376,"source":{"system":"sec-edgar","filing":"0001184778-26-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000118477826000009/ownership.xml","form_type":"4"}},{"id":737583,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38093,"kind":"person","name":"Armitage James O","position":1,"cik":"0001370087","reported_name":"Armitage James O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:09.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":228104,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001370087-26-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000137008726000005/ownership.xml","form_type":"4"}},{"id":737582,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":199246,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001635493-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000163549326000002/ownership.xml","form_type":"4"}},{"id":737581,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:05.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":209331,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001543174-26-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000154317426000005/ownership.xml","form_type":"4"}},{"id":737602,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:03.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":228104,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001184778-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000118477826000007/ownership.xml","form_type":"4"}},{"id":737580,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38090,"kind":"person","name":"Markin Rodney S","position":1,"cik":"0001393415","reported_name":"Markin Rodney S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:03.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":263430,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001393415-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000139341526000002/ownership.xml","form_type":"4"}},{"id":798733,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":51001,"kind":"person","name":"Aggarwal Ajay","position":1,"cik":"0002132312","reported_name":"Aggarwal Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options","published_at":"2026-04-28T22:13:50.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100,000 vest on April 27, 2027 and 8,333 vest monthly for 36 months beginning on May 27, 2027"}],"balance_after":400000,"derivative":{"exercise_price":1.72,"expiration_date":"2036-04-27","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0002132312-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000213231226000004/ownership.xml","form_type":"4"}},{"id":806893,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52250,"kind":"person","name":"Muntner Joshua B","position":1,"cik":"0001651911","reported_name":"Muntner Joshua B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2026-04-17T00:07:04.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":486650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"121,663 vest on April 6, 2027 and 10,139 vest monthly for 36 months thereafter."}],"balance_after":487150,"derivative":{"exercise_price":1.58,"expiration_date":"2036-04-06","underlying":"Common Stock","underlying_shares":486650},"source":{"system":"sec-edgar","filing":"0001651911-26-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000165191126000006/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-16"}},{"id":806891,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2026-04-16T20:03:06.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"75,000 vest on April 14, 2027 and 6,250 vest monthly for 36 months thereafter"}],"balance_after":1279805,"derivative":{"exercise_price":1.63,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001904824-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000190482426000002/ownership.xml","form_type":"4"}},{"id":806892,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52250,"kind":"person","name":"Muntner Joshua B","position":1,"cik":"0001651911","reported_name":"Muntner Joshua B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2026-04-16T20:01:03.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":486650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"121,663 vest on April 6, 2027 and 10,139 vest monthly for 36 months thereafter."}],"balance_after":487150,"derivative":{"exercise_price":1.58,"expiration_date":"2036-04-06","underlying":"Common Stock","underlying_shares":486650},"source":{"system":"sec-edgar","filing":"0001651911-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000165191126000004/ownership.xml","form_type":"4"}},{"id":819163,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:16:32.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"150,000 vest on March 31, 2027 and 12,500 vest monthly for 36 months thereafter"}],"balance_after":968766,"derivative":{"exercise_price":1.62,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001193125-26-140164","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526140164/ownership.xml","form_type":"4"}},{"id":896139,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":65865,"kind":"person","name":"Lindsay Brigitte Ute","position":1,"cik":"0002110286","reported_name":"Lindsay Brigitte Ute","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Options","published_at":"2026-02-18T21:02:04.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 vest on February 13, 2027 and 4,166 vest monthly for 36 months thereafter."}],"balance_after":1025334,"derivative":{"exercise_price":1.6,"expiration_date":"2036-02-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0002110286-26-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000211028626000005/ownership.xml","form_type":"4"}},{"id":896138,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Options","published_at":"2026-02-18T21:01:02.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":368766,"derivative":{"exercise_price":1.56,"exercise_date":"2026-05-17","expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193125-26-056994","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526056994/ownership.xml","form_type":"4"}},{"id":1078292,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-31T20:05:05.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.45,"value":36750.0,"ownership":{"direct":false,"nature":"By minor child"},"balance_after":1345676,"source":{"system":"sec-edgar","filing":"0000950170-25-100882","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000095017025100882/ownership.xml","form_type":"4"}},{"id":1078291,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-31T20:05:05.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":275000,"price":2.45,"value":673750.0,"ownership":{"direct":true},"balance_after":1330676,"source":{"system":"sec-edgar","filing":"0000950170-25-100882","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000095017025100882/ownership.xml","form_type":"4"}},{"id":1099113,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-30T13:39:52.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":168766,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-017072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225017072/ownership.xml","form_type":"4"}},{"id":1099114,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38090,"kind":"person","name":"Markin Rodney S","position":1,"cik":"0001393415","reported_name":"Markin Rodney S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-30T13:38:55.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":222865,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-017071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225017071/ownership.xml","form_type":"4"}},{"id":1099111,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-30T13:38:05.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":168766,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-017070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225017070/ownership.xml","form_type":"4"}},{"id":1100039,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38093,"kind":"person","name":"Armitage James O","position":1,"cik":"0001370087","reported_name":"Armitage James O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-28T00:45:26.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":187539,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-017005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225017005/ownership.xml","form_type":"4"}},{"id":1100038,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-27T23:40:25.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158681,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-016989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225016989/ownership.xml","form_type":"4"}},{"id":1100068,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-27T23:38:42.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":187539,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-016987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000164117225016987/ownership.xml","form_type":"4"}},{"id":1207517,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82018,"kind":"person","name":"Kabbinavar Fairooz","position":1,"cik":"0001774182","reported_name":"Kabbinavar Fairooz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2025-03-13T20:06:04.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":780008,"derivative":{"exercise_price":3.58,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-038717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000095017025038717/ownership.xml","form_type":"4"}},{"id":1207713,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2025-03-13T20:05:04.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":332621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":1295117,"derivative":{"exercise_price":3.58,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":332621},"source":{"system":"sec-edgar","filing":"0000950170-25-038708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000095017025038708/ownership.xml","form_type":"4"}},{"id":1207515,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2025-03-13T20:03:03.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":332621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":979805,"derivative":{"exercise_price":3.58,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":332621},"source":{"system":"sec-edgar","filing":"0000950170-25-038698","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000095017025038698/ownership.xml","form_type":"4"}},{"id":1207745,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82020,"kind":"person","name":"Erlander Mark","position":1,"cik":"0001651537","reported_name":"Erlander Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-03-13T16:02:02.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":758400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":2925098,"derivative":{"exercise_price":3.58,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":758400},"source":{"system":"sec-edgar","filing":"0000950170-25-038694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651537/000095017025038694/ownership.xml","form_type":"4"}},{"id":1326556,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:37:28.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":5,"value":12000.0,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":67716,"source":{"system":"sec-edgar","filing":"0000950170-24-137938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000095017024137938/ownership.xml","form_type":"4"}},{"id":1326555,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:37:28.000Z","date":"2024-12-17","kind":"purchase","planned":false,"acquired":true,"shares":2752,"price":5.4162,"value":14905.3824,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":65316,"source":{"system":"sec-edgar","filing":"0000950170-24-137938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000095017024137938/ownership.xml","form_type":"4"}},{"id":1326554,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:37:28.000Z","date":"2024-12-16","kind":"purchase","planned":false,"acquired":true,"shares":2564,"price":3.83,"value":9820.12,"ownership":{"direct":false,"nature":"By Wife"},"balance_after":62564,"source":{"system":"sec-edgar","filing":"0000950170-24-137938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000095017024137938/ownership.xml","form_type":"4"}},{"id":1330627,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:00:03.000Z","date":"2024-12-12","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.4224,"value":34224.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-24-136725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000095017024136725/ownership.xml","form_type":"4"}},{"id":1333643,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-12T21:05:04.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":11500,"price":2.6,"value":29900.0,"ownership":{"direct":false,"nature":"By minor child"},"balance_after":1059376,"source":{"system":"sec-edgar","filing":"0000950170-24-135767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000095017024135767/ownership.xml","form_type":"4"}},{"id":1333642,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-12T21:05:04.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":350115,"price":2.6,"value":910299.0,"ownership":{"direct":true},"balance_after":1047876,"source":{"system":"sec-edgar","filing":"0000950170-24-135767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000095017024135767/ownership.xml","form_type":"4"}},{"id":1465598,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:09:32.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146974,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030643","document":"wk-form4_1719864565.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030643/wk-form4_1719864565.xml","form_type":"4"}},{"id":1465596,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:09:21.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128201,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030642","document":"wk-form4_1719864555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030642/wk-form4_1719864555.xml","form_type":"4"}},{"id":1465597,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:09:12.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128201,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030641","document":"wk-form4_1719864546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030641/wk-form4_1719864546.xml","form_type":"4"}},{"id":1465614,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:09:01.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146974,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030640","document":"wk-form4_1719864535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828024030640/wk-form4_1719864535.xml","form_type":"4"}},{"id":1465594,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38093,"kind":"person","name":"Armitage James O","position":1,"cik":"0001370087","reported_name":"Armitage James O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:08:50.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146974,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030638","document":"wk-form4_1719864523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030638/wk-form4_1719864523.xml","form_type":"4"}},{"id":1465595,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38090,"kind":"person","name":"Markin Rodney S","position":1,"cik":"0001393415","reported_name":"Markin Rodney S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:08:38.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":182027,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030636","document":"wk-form4_1719864512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030636/wk-form4_1719864512.xml","form_type":"4"}},{"id":1589041,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2024-03-07T23:40:15.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":205008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":962496,"derivative":{"exercise_price":3.51,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":205008},"source":{"system":"sec-edgar","filing":"0001628280-24-009748","document":"wk-form4_1709854805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828024009748/wk-form4_1709854805.xml","form_type":"4"}},{"id":1588862,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82018,"kind":"person","name":"Kabbinavar Fairooz","position":1,"cik":"0001774182","reported_name":"Kabbinavar Fairooz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2024-03-07T23:40:03.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":205008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":630008,"derivative":{"exercise_price":3.51,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":205008},"source":{"system":"sec-edgar","filing":"0001628280-24-009747","document":"wk-form4_1709854793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024009747/wk-form4_1709854793.xml","form_type":"4"}},{"id":1588855,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2024-03-07T23:39:51.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":205008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":647184,"derivative":{"exercise_price":3.51,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":205008},"source":{"system":"sec-edgar","filing":"0001628280-24-009746","document":"wk-form4_1709854782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024009746/wk-form4_1709854782.xml","form_type":"4"}},{"id":1589111,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82020,"kind":"person","name":"Erlander Mark","position":1,"cik":"0001651537","reported_name":"Erlander Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-03-07T18:39:40.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":510000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":2170310,"derivative":{"exercise_price":3.51,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":510000},"source":{"system":"sec-edgar","filing":"0001628280-24-009745","document":"wk-form4_1709854769.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651537/000162828024009745/wk-form4_1709854769.xml","form_type":"4"}},{"id":1704544,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T23:39:51.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.37,"value":41100.0,"ownership":{"direct":true},"balance_after":697761,"source":{"system":"sec-edgar","filing":"0001628280-23-042045","document":"wk-form4_1703029177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828023042045/wk-form4_1703029177.xml","form_type":"4"}},{"id":1742069,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-14T21:24:42.000Z","date":"2023-11-10","kind":"purchase","planned":false,"acquired":true,"shares":22950,"price":0.98,"value":22491.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.95 to $1.01. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request."}],"balance_after":667761,"source":{"system":"sec-edgar","filing":"0001628280-23-038955","document":"wk-form4_1699997066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828023038955/wk-form4_1699997066.xml","form_type":"4"}},{"id":1849149,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38090,"kind":"person","name":"Markin Rodney S","position":1,"cik":"0001393415","reported_name":"Markin Rodney S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:08:01.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":152327,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022742","document":"wk-form4_1687295269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022742/wk-form4_1687295269.xml","form_type":"4"}},{"id":1849148,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38093,"kind":"person","name":"Armitage James O","position":1,"cik":"0001370087","reported_name":"Armitage James O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:06:48.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117274,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022738","document":"wk-form4_1687295199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022738/wk-form4_1687295199.xml","form_type":"4"}},{"id":1849147,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:05:53.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117274,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022736","document":"wk-form4_1687295135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022736/wk-form4_1687295135.xml","form_type":"4"}},{"id":1849164,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:04:48.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117274,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022734","document":"wk-form4_1687295080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828023022734/wk-form4_1687295080.xml","form_type":"4"}},{"id":1849145,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:03:26.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98501,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022732","document":"wk-form4_1687294992.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022732/wk-form4_1687294992.xml","form_type":"4"}},{"id":1849146,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:02:40.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98501,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022731","document":"wk-form4_1687294950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022731/wk-form4_1687294950.xml","form_type":"4"}},{"id":1949816,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2023-03-16T21:42:28.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":167088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":442176,"derivative":{"exercise_price":1.72,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":167088},"source":{"system":"sec-edgar","filing":"0001628280-23-008357","document":"wf-form4_167900293568224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023008357/wf-form4_167900293568224.xml","form_type":"4"}},{"id":1949961,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2023-03-16T21:42:11.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":197472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":757488,"derivative":{"exercise_price":1.72,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":197472},"source":{"system":"sec-edgar","filing":"0001628280-23-008356","document":"wf-form4_167900291678685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828023008356/wf-form4_167900291678685.xml","form_type":"4"}},{"id":1950160,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":115482,"kind":"person","name":"Kelemen Vicki","position":1,"cik":"0001815809","reported_name":"Kelemen Vicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP and COO"}}],"security":"Stock Options","published_at":"2023-03-16T17:41:54.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":125520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":698304,"derivative":{"exercise_price":1.72,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":125520},"source":{"system":"sec-edgar","filing":"0001628280-23-008355","document":"wf-form4_167900290271838.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815809/000162828023008355/wf-form4_167900290271838.xml","form_type":"4"}},{"id":1950029,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82020,"kind":"person","name":"Erlander Mark","position":1,"cik":"0001651537","reported_name":"Erlander Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-03-16T17:41:38.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":482064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":1664477,"derivative":{"exercise_price":1.72,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":482064},"source":{"system":"sec-edgar","filing":"0001628280-23-008354","document":"wf-form4_167900288656705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651537/000162828023008354/wf-form4_167900288656705.xml","form_type":"4"}},{"id":2102446,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82020,"kind":"person","name":"Erlander Mark","position":1,"cik":"0001651537","reported_name":"Erlander Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-29T16:11:12.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":10000,"price":1.43,"value":14300.0,"ownership":{"direct":true},"balance_after":24481,"source":{"system":"sec-edgar","filing":"0001628280-22-030946","document":"wf-form4_166975625707899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651537/000162828022030946/wf-form4_166975625707899.xml","form_type":"4"}},{"id":2139085,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38093,"kind":"person","name":"Armitage James O","position":1,"cik":"0001370087","reported_name":"Armitage James O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T20:22:42.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":13000,"price":1.5564,"value":20233.2,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shirley A. Young is the Trustee of the Shirley A. Young Revocable Trust DTD 2/10/2004.  Shirley A. Young is the wife of James Armitage."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001628280-22-026245","document":"wf-form4_166551974738442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022026245/wf-form4_166551974738442.xml","form_type":"4"}},{"id":2153943,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-20T22:08:57.000Z","date":"2022-09-19","kind":"purchase","acquired":true,"shares":15000,"price":1.635,"value":24525.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.64. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request."}],"balance_after":113788,"source":{"system":"sec-edgar","filing":"0001628280-22-025265","document":"wf-form4_166371172268717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022025265/wf-form4_166371172268717.xml","form_type":"4"}},{"id":2155393,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T12:37:44.000Z","date":"2022-09-15","kind":"purchase","acquired":true,"shares":3600,"price":1.72,"value":6192.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-22-025101","document":"wf-form4_166359105093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022025101/wf-form4_166359105093640.xml","form_type":"4"}},{"id":2155392,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T12:37:44.000Z","date":"2022-09-15","kind":"purchase","acquired":true,"shares":6400,"price":1.715,"value":10976.0,"ownership":{"direct":true},"balance_after":6400,"source":{"system":"sec-edgar","filing":"0001628280-22-025101","document":"wf-form4_166359105093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022025101/wf-form4_166359105093640.xml","form_type":"4"}},{"id":2155398,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T12:37:26.000Z","date":"2022-09-15","kind":"purchase","acquired":true,"shares":150000,"price":1.71,"value":256500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.65 to $1.78. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request."}],"balance_after":644811,"source":{"system":"sec-edgar","filing":"0001628280-22-025100","document":"wf-form4_166359103116463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828022025100/wf-form4_166359103116463.xml","form_type":"4"}},{"id":2155560,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-19T12:37:06.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":30000,"price":1.557,"value":46710.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.555 to $1.56. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001628280-22-025099","document":"wf-form4_166359101233703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828022025099/wf-form4_166359101233703.xml","form_type":"4"}},{"id":2211550,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-07-06T20:10:40.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":28858,"price":2.6,"value":75030.8,"ownership":{"direct":true},"balance_after":60716,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001628280-22-018607","document":"wf-form4_165713821643094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022018607/wf-form4_165713821643094.xml","form_type":"4"}},{"id":2211549,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T20:10:40.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":28858,"price":2.6,"value":75030.8,"ownership":{"direct":false,"nature":"Trust"},"balance_after":98788,"source":{"system":"sec-edgar","filing":"0001628280-22-018607","document":"wf-form4_165713821643094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022018607/wf-form4_165713821643094.xml","form_type":"4"}},{"id":2237471,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":316.08,"exercise_date":"2014-12-11","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":195},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237470,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":516.96,"exercise_date":"2016-03-17","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237469,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":372.96,"exercise_date":"2017-01-04","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237468,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":51.84,"exercise_date":"2018-10-04","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":530},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237467,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":21.6,"exercise_date":"2019-01-23","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":755},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237466,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":44734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":2.48,"exercise_date":"2020-06-20","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":44734},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237465,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":28858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Expiration date of the stock options was extended to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237464,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 22,000 stock options to June 9, 2022 from June 10, 2022. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":7.98,"exercise_date":"2022-06-09","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2237463,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2022-06-09T23:48:59.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 26,800 stock options to June 9, 2022 from March 9, 2023. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024."}],"balance_after":125317,"derivative":{"exercise_price":2.5,"exercise_date":"2022-06-09","expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-016731","document":"wf-form4_165481851971252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022016731/wf-form4_165481851971252.xml","form_type":"4"}},{"id":2337356,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-11T19:11:44.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":89574,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005854","document":"wf-form4_164702588154244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828022005854/wf-form4_164702588154244.xml","form_type":"4"}},{"id":2339542,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:43:34.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":89574,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005797","document":"wf-form4_164695579568634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005797/wf-form4_164695579568634.xml","form_type":"4"}},{"id":2339543,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:43:11.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70801,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005796","document":"wf-form4_164695577272689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005796/wf-form4_164695577272689.xml","form_type":"4"}},{"id":2339541,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30048,"kind":"person","name":"Mohindru Mani","position":1,"cik":"0001664708","reported_name":"Mohindru Mani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:42:22.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70801,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005794","document":"wf-form4_164695571887372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005794/wf-form4_164695571887372.xml","form_type":"4"}},{"id":2339540,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38090,"kind":"person","name":"Markin Rodney S","position":1,"cik":"0001393415","reported_name":"Markin Rodney S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:41:55.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124627,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Stock Options","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005793","document":"wf-form4_164695568373039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005793/wf-form4_164695568373039.xml","form_type":"4"}},{"id":2339752,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2022-03-10T23:40:57.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":170016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026."}],"balance_after":560016,"derivative":{"exercise_price":2.5,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":170016},"source":{"system":"sec-edgar","filing":"0001628280-22-005792","document":"wf-form4_164695562170769.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828022005792/wf-form4_164695562170769.xml","form_type":"4"}},{"id":2339539,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:38:47.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":125317,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005789","document":"wf-form4_164695550374678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005789/wf-form4_164695550374678.xml","form_type":"4"}},{"id":2339538,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38093,"kind":"person","name":"Armitage James O","position":1,"cik":"0001370087","reported_name":"Armitage James O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:38:17.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":89574,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005788","document":"wf-form4_164695546998763.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005788/wf-form4_164695546998763.xml","form_type":"4"}},{"id":2340091,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":129266,"kind":"person","name":"Ruffner Katherine L","position":1,"cik":"0001872306","reported_name":"Ruffner Katherine L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2022-03-10T18:42:46.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":170016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026."}],"balance_after":370016,"derivative":{"exercise_price":2.5,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":170016},"source":{"system":"sec-edgar","filing":"0001628280-22-005795","document":"wf-form4_164695574769782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872306/000162828022005795/wf-form4_164695574769782.xml","form_type":"4"}},{"id":2340033,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":115482,"kind":"person","name":"Kelemen Vicki","position":1,"cik":"0001815809","reported_name":"Kelemen Vicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP and COO"}}],"security":"Stock Options","published_at":"2022-03-10T18:40:11.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":170016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026."}],"balance_after":572784,"derivative":{"exercise_price":2.5,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":170016},"source":{"system":"sec-edgar","filing":"0001628280-22-005791","document":"wf-form4_164695558683169.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815809/000162828022005791/wf-form4_164695558683169.xml","form_type":"4"}},{"id":2339829,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82020,"kind":"person","name":"Erlander Mark","position":1,"cik":"0001651537","reported_name":"Erlander Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2022-03-10T18:39:37.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":370128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"92,532 vest on 3/09/2023. 7,711 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026."}],"balance_after":1185400,"derivative":{"exercise_price":2.5,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":370128},"source":{"system":"sec-edgar","filing":"0001628280-22-005790","document":"wf-form4_164695553669989.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651537/000162828022005790/wf-form4_164695553669989.xml","form_type":"4"}},{"id":2561799,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":30049,"kind":"person","name":"PACE GARY W","position":1,"cik":"0001184778","reported_name":"PACE GARY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-22T21:54:12.000Z","date":"2021-09-21","kind":"purchase","acquired":true,"shares":30000,"price":6.75,"value":202500.0,"ownership":{"direct":true},"balance_after":494811,"source":{"system":"sec-edgar","filing":"0001628280-21-019057","document":"wf-form4_163234764145489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184778/000162828021019057/wf-form4_163234764145489.xml","form_type":"4"}},{"id":2571921,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-13T12:12:36.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":5000,"price":6.32,"value":31600.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001628280-21-018433","document":"wf-form4_163153514276157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828021018433/wf-form4_163153514276157.xml","form_type":"4"}},{"id":2571920,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-13T12:12:36.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":5000,"price":6.35,"value":31750.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001628280-21-018433","document":"wf-form4_163153514276157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828021018433/wf-form4_163153514276157.xml","form_type":"4"}},{"id":2571919,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-13T12:12:36.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":10000,"price":6.38,"value":63800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001628280-21-018433","document":"wf-form4_163153514276157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828021018433/wf-form4_163153514276157.xml","form_type":"4"}},{"id":2571918,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-13T12:12:36.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":5000,"price":6.75,"value":33750.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-21-018433","document":"wf-form4_163153514276157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828021018433/wf-form4_163153514276157.xml","form_type":"4"}},{"id":2571917,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-13T12:12:36.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":5000,"price":6.62,"value":33100.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001628280-21-018433","document":"wf-form4_163153514276157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828021018433/wf-form4_163153514276157.xml","form_type":"4"}},{"id":2634165,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":129266,"kind":"person","name":"Ruffner Katherine L","position":1,"cik":"0001872306","reported_name":"Ruffner Katherine L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2021-07-14T16:00:35.000Z","date":"2021-07-12","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vest on 7/12/2022. The remainder vest in equal installments monthly for 36 months beginning on 8/12/2022 through 7/12/2025."}],"balance_after":200000,"derivative":{"exercise_price":6.55,"expiration_date":"2031-07-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001628280-21-013826","document":"wf-form4_162629281654783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872306/000162828021013826/wf-form4_162629281654783.xml","form_type":"4"}},{"id":2636102,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":36097,"kind":"person","name":"Levine James E.","position":1,"cik":"0001463151","reported_name":"Levine James E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-12T20:16:15.000Z","date":"2021-07-12","kind":"grant","acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"97,500 vest on 7/12/2022. 8,125 vest monthly for 36 months beginning on 8/12/2022 through 7/12/2025."}],"balance_after":390000,"derivative":{"exercise_price":6.55,"expiration_date":"2031-07-12","underlying":"Stock Options","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001628280-21-013754","document":"wf-form4_162612095825628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463151/000162828021013754/wf-form4_162612095825628.xml","form_type":"4"}},{"id":2668041,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":44734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":2.48,"exercise_date":"2020-06-20","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":44734},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668040,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":21.6,"exercise_date":"2019-01-23","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":755},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668039,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":51.84,"exercise_date":"2018-10-04","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":530},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668038,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":372.96,"exercise_date":"2017-01-04","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668037,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":516.96,"exercise_date":"2016-03-17","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}}],"next_cursor":"2021-06-15T14:06:43.000000Z,2668037"}